G

Gyroscope Therapeutics

79 employees

Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.

Basic info

Industry

biotechnology research

Sectors

Surgical Device
Biotechnology
Health Care
Gene Therapy
Therapeutics
Genetics
Complement
Ophthalmology

Date founded

2016

Funding rounds raised

Total raised

$149M

from 10 investors over 10 rounds

G

Gyroscope Therapeutics raised $149M on March 26, 2021

Investors: Tetragon Financial Group Limited, Forbion, Sofinnova Ventures, Russia technology fund, T. Rowe Price, Cambridge Innovation Capital plc, Fosun Pharma and Syncona Limited

G

Gyroscope Therapeutics raised $61M on September 3, 2019

Investors: Syncona Limited and Cambridge Innovation Capital plc

G

Gyroscope Therapeutics raised undisclosed on March 31, 2017

Investors: Syncona Limited

FAQ